Argentum Medical has been awarded a contract by the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services for its Silverlon burn dressings.
The Silverlon burn dressings will be used for patients affected by mass casualty incidents, including trauma, burn, or sulfur-mustard exposure.
“Five years ago, after a rigorous evaluation process, Silverlon was selected as a burn dressing to enhance national preparedness,” Raul Brizuela, president and CEO of Argentum Medical, said. “With this new contract, we will continue to provide this vital product in order to ensure a swift and effective response in case of a mass casualty event.”
Silverlon dressings are used in civilian operating rooms, hospitals, and healthcare facilities around the globe. In 2019, the Food and Drug Administration approved Vapor Sulfur Mustard Indication for Silverlon Burn and Wound Care products after studies showed it was appropriate for use on certain injuries caused by sulfur mustard exposure.
Silverlon is also used for partial and full thickness wounds, 1st and 2nd degree burns, dermal ulcers, vascular access, surgical and traumatic wounds, among other uses. Advanced development and initial procurement of the product was supported by the Biomedical Advanced Research for Preparedness and Response (BARDA), which is part of the HHS Office of the Assistant Secretary for Preparedness and Response.
“We have been proud to provide Silverlon to the U.S. government for the last five years, but we haven’t rested. Significant investments have been spent on laboratory testing and manufacturing to make sure Silverlon achieves the highest levels of quality, safety, and efficacy for patients,” Brizuela said. “Silverlon is the only product with an FDA indication for the management of sulfur-mustard injuries and the only silver dressing with an MRI indication. Many clinical studies have been published on what Silverlon can do, and we are honored to be able to do our part to keep the country prepared.”